Ann: Race Strategic Update August 2023, page-542

I will take a punt on a release mid/late next week to allow review by SH over the weekend so questions can be asked at the AGM. Otherwise what a disappointing AGM that will be over "swiftly"... I jest.

Regardless, I agree with Dr T that this release needs to be right, not quick so I'm somewhat indifferent and happy with "ready when it's ready". A rejection of this strategy would be brutal to sentiment, and rightly so. I view that the market still believes the main risk with RAC is management's ability, not the asset.

I, however am positive and I do believe that this strategy will clear in respect of the clinical programs and funding. I do hope there is a clear commercialisation strategy as well. If we're "standing on the goal line" the finesse must be to mitigate dilution and ensure maximum speed to score the goal?